APIM Therapeutics Closes a Financing Round
TRONDHEIM, Norway, October 17, 2012 /PRNewswire/ — – Financing will be used to further develop APIM Therapeutics lead anti-cancer compound towards late preclinical development. APIM Therapeutics, a preclinical biotech company …